Expands epinephrine administration mechanisms permitted in schools.

This New Jersey bill (A 181) expands school policies to allow any FDA-approved epinephrine device - not just auto-injectors - for emergency use during anaphylactic reactions. It requires schools to develop policies with specific parental authorization forms (including liability waivers), secure storage of epinephrine accessible to nurses or trained staff, and clear protocols for emergency administration. The bill directly affects public and nonpublic schools, students with known allergies (requiring parental consent), and school staff who may administer epinephrine during emergencies - even without prior parental consent for that specific incident. Key provisions mandate that trained staff can act immediately if a student shows signs of anaphylaxis, and schools must maintain backup epinephrine supplies accessible during school activities. The bill is currently pending before the Assembly Health Committee (introduced January 13, 2026).